Teva Hits Back In Gilead Patent Suit Over HIV Drug
Teva Pharmaceutical Industries Ltd. has struck back with patent invalidity counterclaims against rival Gilead Sciences Inc. in an infringement case involving drug treatments for HIV....To view the full article, register now.
Already a subscriber? Click here to view full article